News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
MorphoSys AG: Announcement Of The Convening Of The AGM In Munich/Germany On 23 May 2014 According To Sec. 121 Para. 4a Aktg With The Objective Of Europe-Wide Distribution
April 11, 2014
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Martinsried / Munich, Germany, April 11, 2014 (GLOBE NEWSWIRE) --
MorphoSys AG
Martinsried/Planegg
Securities Code Number: 663200
ISIN: DE0006632003
Help employers find you! Check out all the
jobs
and
post your resume
.
Twitter
LinkedIn
Facebook
Email
Print
Europe
MORE ON THIS TOPIC
Insights
Denmark’s foundation‑fueled biotech boom redraws the Nordic map
July 27, 2026
·
4 min read
·
Jennifer C. Smith-Parker
Insights
Nordic biotech’s next act: From fragmentation to global force
July 23, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Manufacturing
Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity
July 21, 2026
·
2 min read
·
Nick Paul Taylor
Insights
Golden Triangle still dominates, but talent and capital gaps slow biotech growth
July 1, 2026
·
3 min read
·
Jennifer C. Smith-Parker